G.B. Pant University of Agriculture & Technology Pantnagar (UP) India
Master of Science (MSc) (Biochemistry)
1976-1979
Babu Tekwani Skills
Academic Writing
Animal Models
Assay Development
Biochemistry
Bioinformatics
Biology
Biotechnology
Business Development
Cell
Cell Culture
Cellular Assays
Characterization
Clinical Development
Clinical Research
Communication
Cross-functional Team Leadership
Decision-Making
Director level
Drug Discovery
Drug Discovery Platforms
Drug Metabolism
Emerging Infectious Diseases
Executive Leadership
Federal Grants Management
Genomics
Grant Research
High Throughput Screening
In Vitro
In Vivo
Infectious Diseases
Interdisciplinary Research
Laboratory
Leadership
Lifesciences
Medical Research
Microbiology
Molecular Biology
Molecular Cloning
Neurological Disorders
Non-profit Management
Pharmacokinetics
Pharmacology
Pre-clinical Studies
Project Development
Project Management
Protein Chemistry
Protein Purification
Publications
Research
Research Funding
Research Proposals
Research Skills
Research and Development (R&D)
Science
Scientific Communications
Strategic Planning
Team Leadership
Toxicology
Translational Research
Validation
biomedical Communications
strategic and operational leadership
Public Speaking
See 13+See Less
Strategy
Microsoft Office
High Throughput
Microsoft Excel
Pharmaceutical Industry
Babu Tekwani Summary
Babu Tekwani, based in Birmingham, AL, US, is currently a Vice President Research And Development at Vala Sciences. Babu Tekwani brings experience from previous roles at GlobaCure, Southern Research and University of Mississippi. Babu Tekwani holds a 1981 - 1984 Ph.D. in Biochemistry, Molecular Biology, Molecular & Biochemical Pathogenesis @ Central Drug Research Institute (CDRI) & University of Lucknow, Lucknow (UP) India. With a robust skill set that includes Academic Writing, Animal Models, Assay Development, Biochemistry, Bioinformatics and more. Babu Tekwani has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Babu Tekwani?
Find contact details for 700 million professionals.